CFAP410 and amyotrophic lateral sclerosis: Though the occurrence rate of mutations in CFAP410 suggests it is unlikely to be the primary driver of ALS, we sought to characterize these variants as potential risk alleles based on these predictions, by assaying their effects on motor neurons and further cell types.